Briana Contreras, associate editor of Managed Healthcare Executive, spoke with Mark Poling, chief product officer of Zipari, a health insurance tech organization, about how a direct-to-consumer model can simplify the enrollment process. He also shared the benefits the model has to health insurance systems’ operations.
In this part five series, participants give their opinions on which drugs newer to the market in the last 12 months hold the most promise to reducing morbidity and mortality. Participants also shared which drug in the pipeline holds the most promise. MHE's annual pharmacy survey had over 225 respondents. We will be posting the results over the next few days.
Chances of left ventricular ejection fraction almost disappeared when patient took the ACE-inhibitor lisinopril during treatment with trastuzumab/anthracycline, according to research presented at ASCO.
Former OptumRx executive, Gina Guinasso, J.D., is president of the newly named retail venture.
Immune-related AEs can occur one to two years after treatment, are more common in combination treatments, and can be difficult to manage.
Predictions that the company would make a major move to dominate American healthcare have not come to pass. So far.
The Alzheimer's Association praises the approval but not the price tag. A Harvard Medical School professor who resigned from an FDA advisory committee says the OK "was probably the worst approval decision in recent U.S. history" in his resignation letter.
In this part four series, participants give their opinions on the biggest driver of specialty drug expenditures this year and what the most significant change in contracts between plan sponsors and PBMs could be in the near future. MHE's annual pharmacy survey had over 225 respondents. We will be posting the results over the next few days.
Nurtec ODT is the first oral CGRP antagonist approved for migraine prevention, says its maker, Biohaven.
According to the CDC, use of any contraception has remained stable in the United States. From 2015 to 2017, approximately 2 out of 3 girls and women ages 15 to 49 used some form of contraception,and a similar proportion did so from 2017 to 2019.
The pandemic caused a temporary dip in 2020. But as public health spending has decreased, sexually transmitted disease trends have increased.
A large proportion of patients with muscle-invasive bladder cancer responded to transurethral resection of bladder tumor and a drug cocktail that included gemcitabine, cisplatin and Opdivo (nivolumab).
In this part three series, participants give their opinions on the most effective ways to reduce traditional and specialty pharmaceutical costs. MHE's annual pharmacy survey had over 225 respondents. We will be posting the results over the next several days.
In this part two series, participants give their opinions on the lasting effects of the pandemic. MHE's annual pharmacy survey had over 225 respondents. We will be posting the results over the next several days.
Clinical data integration can mean navigating through an obstacle course of organizational and technical challenges. But it can show its ROI bona fides with digital chart review and other efforts.
Respondents upbeat about COVID-19 vaccination. MHE's annual pharmacy survey had over 225 respondents. We will be posting the results over the next several days.
Study shows an association between greater "eveningness" (being awake and alert at night) and cannabis use and binge drinking.
In this week's episode Senior Editor Peter Wehrwein chats with Founder and Executive Chairwoman of Caravan Health Lynn Barr. The two discussed the relationship of payers and ACOs and the approach toward the direct contracting model.
Research and investment are increasing into psilocybin and MDMA as treatments for several mental health disorders.
Strategies are needed that take most, if not, all of the burden away from the patient so that RPM enhances their experience with their care. Both telehealth and RPM have those elements needed to improve the patient experience, including good communication between doctors and patients and improved patient engagement.
The jury is still out. Several companies have high hopes for candidates under development.
As patients become discerning consumers of healthcare, providers are focused on implementing processes and technologies that enhance the entire experience, from care delivery through to payment obligations.
According to a new West Health/Gallup survey, less than 20% of all Americans believe Medicare negotiation would hurt innovation or market competition, including a minority of Republicans.
Today's approval goes against the advice of an outside advisory committee.
Semaglutide injection is a weekly injection for chronic weight management in adults.
Researchers are making progress in identifying drugs that target certain mutations.
Harvard researchers say, well, maybe.
Ten years ago, specialty accounted for 15% to 20% of the money spent on drugs, according to Prem Shah, executive vice president of specialty pharmacy and product innovation at CVS Health.
Phase 1b results show manageable toxicities with Venclexta and Rydapt.
